Artículos

Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder / Eduard Vieta Pascual en Journal of Clinical Psychopharmacology, Año 2001 - Vol. 21 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 5 (Octubre) . - pp. 469-473 Título : Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder Tipo de documento: texto impreso Autores: Eduard Vieta Pascual, Autor ; María Reinares, Autor ; Bàrbara Corbella, Autor Fecha de publicación: 2023 Artículo en la página: pp. 469-473 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Trastornos de somnolencia excesiva, Resistencia al medicamento, Hospitalización Resumen: The aim of this study was to estimate the long-term effectiveness of olanzapine as adjunctive therapy in patients with bipolar disorder who exhibited an inadequate response to mood stabilizers. Twenty-three Research Diagnostic Criteria (RDC) patients with bipolar I and II were assessed by means of the Schedule for Affective Disorders and Schizophrenia and entered if they gave their consent to participate. Link: ./index.php?lvl=notice_display&id=31107 [artículo] Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder [texto impreso] / Eduard Vieta Pascual, Autor ; María Reinares, Autor ; Bàrbara Corbella, Autor . - 2023 . - pp. 469-473. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 5 (Octubre) . - pp. 469-473 Palabras clave: Antipsicóticos, Trastornos de somnolencia excesiva, Resistencia al medicamento, Hospitalización Resumen: The aim of this study was to estimate the long-term effectiveness of olanzapine as adjunctive therapy in patients with bipolar disorder who exhibited an inadequate response to mood stabilizers. Twenty-three Research Diagnostic Criteria (RDC) patients with bipolar I and II were assessed by means of the Schedule for Affective Disorders and Schizophrenia and entered if they gave their consent to participate. Link: ./index.php?lvl=notice_display&id=31107

Tolerability of combined treatment with lithium and paroxetine in patients with bipolar disorder and depression / Andrea Fagiolini en Journal of Clinical Psychopharmacology, Año 2001 - Vol. 21 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 5 (Octubre) . - pp. 474-478 Título : Tolerability of combined treatment with lithium and paroxetine in patients with bipolar disorder and depression Tipo de documento: texto impreso Autores: Andrea Fagiolini, Autor ; Daniel J. Buysse, Autor ; Ellen Frank, Autor Fecha de publicación: 2023 Artículo en la página: pp. 474-478 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno bipolar, Trastorno depresivo, Terapia con medicamentos, Litio, Paroxetina, Inhibidores selectivos de la recaptación de serotonina, Síndrome serotoninérgico. Resumen: Patients with bipolar disorder are often prescribed lithium in combination with a selective serotonin reuptake inhibitor. Doubts still remain, however, about the safety of the combination, particularly with regard to the risk of developing a serotonin syndrome. Link: ./index.php?lvl=notice_display&id=31108 [artículo] Tolerability of combined treatment with lithium and paroxetine in patients with bipolar disorder and depression [texto impreso] / Andrea Fagiolini, Autor ; Daniel J. Buysse, Autor ; Ellen Frank, Autor . - 2023 . - pp. 474-478. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 5 (Octubre) . - pp. 474-478 Palabras clave: Trastorno bipolar, Trastorno depresivo, Terapia con medicamentos, Litio, Paroxetina, Inhibidores selectivos de la recaptación de serotonina, Síndrome serotoninérgico. Resumen: Patients with bipolar disorder are often prescribed lithium in combination with a selective serotonin reuptake inhibitor. Doubts still remain, however, about the safety of the combination, particularly with regard to the risk of developing a serotonin syndrome. Link: ./index.php?lvl=notice_display&id=31108

Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics / Steven G. Potkin en Journal of Clinical Psychopharmacology, Año 2001 - Vol. 21 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 5 (Octubre) . - pp. 479-483 Título : Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics Tipo de documento: texto impreso Autores: Steven G. Potkin, Autor ; Kirsten Fleming, Autor Fecha de publicación: 2023 Artículo en la página: pp. 479-483 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Clozapina, Cognición, Trastornos cognitivos, Haloperidol, Pruebas neuropsicológicas, Esquizofrenia. Resumen: Neurocognition and clinical symptomatology were evaluated in 27 patients with schizophrenia during a double-blind, placebo-controlled, crossover study involving clozapine, an atypical antipsychotic agent, and haloperidol, a conventional neuroleptic. Patients were assessed 5 to 6 weeks after initiation of each phase. Link: ./index.php?lvl=notice_display&id=31109 [artículo] Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics [texto impreso] / Steven G. Potkin, Autor ; Kirsten Fleming, Autor . - 2023 . - pp. 479-483. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 5 (Octubre) . - pp. 479-483 Palabras clave: Antipsicóticos, Clozapina, Cognición, Trastornos cognitivos, Haloperidol, Pruebas neuropsicológicas, Esquizofrenia. Resumen: Neurocognition and clinical symptomatology were evaluated in 27 patients with schizophrenia during a double-blind, placebo-controlled, crossover study involving clozapine, an atypical antipsychotic agent, and haloperidol, a conventional neuroleptic. Patients were assessed 5 to 6 weeks after initiation of each phase. Link: ./index.php?lvl=notice_display&id=31109

A placebo-controlled pilot study of the ampakine cx516 added to clozapine in schizophrenia / Donald C. Goff en Journal of Clinical Psychopharmacology, Año 2001 - Vol. 21 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 5 (Octubre) . - pp. 484-487 Título : A placebo-controlled pilot study of the ampakine cx516 added to clozapine in schizophrenia Tipo de documento: texto impreso Autores: Donald C. Goff, Autor ; Leslie Leahy, Autor ; Ileana Berman, Autor Fecha de publicación: 2023 Artículo en la página: pp. 484-487 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Clozapina, Cognición, Dioxoles, Memoria, Piperidinas, Pruebas Psicológicas, Esquizofrenia. Resumen: CX516, a positive modulator of the glutamatergic α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor, improves performance in tasks requiring learning and memory in animals. CX516 was added to clozapine in 4-week, placebo-controlled, dose-finding (N = 6) and fixed-dose (N = 13) trials. Link: ./index.php?lvl=notice_display&id=31110 [artículo] A placebo-controlled pilot study of the ampakine cx516 added to clozapine in schizophrenia [texto impreso] / Donald C. Goff, Autor ; Leslie Leahy, Autor ; Ileana Berman, Autor . - 2023 . - pp. 484-487. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 5 (Octubre) . - pp. 484-487 Palabras clave: Antipsicóticos, Clozapina, Cognición, Dioxoles, Memoria, Piperidinas, Pruebas Psicológicas, Esquizofrenia. Resumen: CX516, a positive modulator of the glutamatergic α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor, improves performance in tasks requiring learning and memory in animals. CX516 was added to clozapine in 4-week, placebo-controlled, dose-finding (N = 6) and fixed-dose (N = 13) trials. Link: ./index.php?lvl=notice_display&id=31110

Clinical predictors of drug response in obsessive-compulsive disorder / Stefano Erzegovesi en Journal of Clinical Psychopharmacology, Año 2001 - Vol. 21 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 5 (Octubre) . - pp. 488-492 Título : Clinical predictors of drug response in obsessive-compulsive disorder Tipo de documento: texto impreso Autores: Stefano Erzegovesi, Autor ; Maria Cristina Cavallini, Autor ; Paolo Cavedini, Autor Fecha de publicación: 2023 Artículo en la página: pp. 488-492 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Citalopram, Resistencia a los medicamentos, Fluvoxamina, Trastorno obsesivo-compulsivo, Paroxetina, Pruebas psicológicas, Inhibidores selectivos de la recaptación de serotonina. Resumen: The aim of this study was to evaluate which clinical variables might influence the antiobsessional response to proserotonergic drugs in a sample of patients with obsessive-compulsive disorder (OCD). One hundred fifty-nine patients with DSM-IV OCD underwent a 12-week standardized treatment with fluvoxamine, clomipramine, citalopram, or paroxetine. Link: ./index.php?lvl=notice_display&id=31111 [artículo] Clinical predictors of drug response in obsessive-compulsive disorder [texto impreso] / Stefano Erzegovesi, Autor ; Maria Cristina Cavallini, Autor ; Paolo Cavedini, Autor . - 2023 . - pp. 488-492. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 5 (Octubre) . - pp. 488-492 Palabras clave: Citalopram, Resistencia a los medicamentos, Fluvoxamina, Trastorno obsesivo-compulsivo, Paroxetina, Pruebas psicológicas, Inhibidores selectivos de la recaptación de serotonina. Resumen: The aim of this study was to evaluate which clinical variables might influence the antiobsessional response to proserotonergic drugs in a sample of patients with obsessive-compulsive disorder (OCD). One hundred fifty-nine patients with DSM-IV OCD underwent a 12-week standardized treatment with fluvoxamine, clomipramine, citalopram, or paroxetine. Link: ./index.php?lvl=notice_display&id=31111

Lack of effect of citalopram on the steady-state pharmacokinetics of carbamazepine in healthy male subjects / Svend Erik Møller en Journal of Clinical Psychopharmacology, Año 2001 - Vol. 21 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 5 (Octubre) . - pp. 493-499 Título : Lack of effect of citalopram on the steady-state pharmacokinetics of carbamazepine in healthy male subjects Tipo de documento: texto impreso Autores: Svend Erik Møller, Autor ; Frank Larsen, Autor ; Azhar Z. Khan, Autor Fecha de publicación: 2023 Artículo en la página: pp. 493-499 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Anticonvulsivos, Carbamazepina, Citalopram, Interacciones medicamentosas, Inhibidores selectivos de la recaptación de serotonina. Resumen: Carbamazepine, a drug used in the treatment of seizure disorders, and citalopram, a highly selective serotonin reuptake inhibitor used for the treatment of depression and other psychiatric disorders, are both metabolized predominantly by the cytochrome P4503A4 isozyme. In this study, the effect of subchronic administration of citalopram on the steady-state pharmacokinetics of carbamazepine was evaluated in 12 healthy male subjects. Link: ./index.php?lvl=notice_display&id=31112 [artículo] Lack of effect of citalopram on the steady-state pharmacokinetics of carbamazepine in healthy male subjects [texto impreso] / Svend Erik Møller, Autor ; Frank Larsen, Autor ; Azhar Z. Khan, Autor . - 2023 . - pp. 493-499. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 5 (Octubre) . - pp. 493-499 Palabras clave: Anticonvulsivos, Carbamazepina, Citalopram, Interacciones medicamentosas, Inhibidores selectivos de la recaptación de serotonina. Resumen: Carbamazepine, a drug used in the treatment of seizure disorders, and citalopram, a highly selective serotonin reuptake inhibitor used for the treatment of depression and other psychiatric disorders, are both metabolized predominantly by the cytochrome P4503A4 isozyme. In this study, the effect of subchronic administration of citalopram on the steady-state pharmacokinetics of carbamazepine was evaluated in 12 healthy male subjects. Link: ./index.php?lvl=notice_display&id=31112

Drug glucuronidation in clinical psychopharmacology / Heidi L. Liston en Journal of Clinical Psychopharmacology, Año 2001 - Vol. 21 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 5 (Octubre) . - pp. 500-515 Título : Drug glucuronidation in clinical psychopharmacology Tipo de documento: texto impreso Autores: Heidi L. Liston, Autor ; John C. Markowitz, Autor ; C. Lindsay DeVane, Autor Fecha de publicación: 2023 Artículo en la página: pp. 500-515 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Sistema enzimático citocromo P-450, Interacción medicamentosa, Trastornos mentales, Psicofarmacología, Medicamentos psicotrópicos. Resumen: Glucuronidation is a phase II metabolic process and one of the most common pathways in the formation of hydrophilic drug metabolites. At least 33 families of uridine diphosphate-glucuronosyltransferases have been identified in vitro, and specific nomenclature similar to that used to classify the cytochrome (CYP) P450 system has been established. Link: ./index.php?lvl=notice_display&id=31113 [artículo] Drug glucuronidation in clinical psychopharmacology [texto impreso] / Heidi L. Liston, Autor ; John C. Markowitz, Autor ; C. Lindsay DeVane, Autor . - 2023 . - pp. 500-515. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 5 (Octubre) . - pp. 500-515 Palabras clave: Sistema enzimático citocromo P-450, Interacción medicamentosa, Trastornos mentales, Psicofarmacología, Medicamentos psicotrópicos. Resumen: Glucuronidation is a phase II metabolic process and one of the most common pathways in the formation of hydrophilic drug metabolites. At least 33 families of uridine diphosphate-glucuronosyltransferases have been identified in vitro, and specific nomenclature similar to that used to classify the cytochrome (CYP) P450 system has been established. Link: ./index.php?lvl=notice_display&id=31113